Scilex Holding (SCLX) Debt to Equity (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Debt to Equity of -$0.32 for Q1 2026, down 70.48% year-over-year from -$1.08 in Q1 2025, and up 37.52% on a QoQ basis from -$0.51 in Q4 2025.
Scilex Holding (SCLX) Debt to Equity (2021 - 2026) Analysis & Trends
Scilex Holding (SCLX) has reported Debt to Equity for 6 consecutive years, with -$0.32 the latest figure, recorded in Q1 2026.
- In Q1 2026, Debt to Equity fell 70.48% year-over-year to -$0.32; the TTM figure through Mar 2026 stood at -$0.32 (down 70.48% YoY), while the FY2025 annual figure was -$0.51, down 174.45% from the prior year.
- Debt to Equity came in at -$0.32 for Q1 2026 at Scilex Holding, up from -$0.51 in the prior quarter.
- The five-year high for Debt to Equity was $1.53 in Q2 2023, with the low at -$0.75 in Q3 2023.
- Average Debt to Equity over 5 years is -$0.22, with a median of -$0.29 recorded in 2025.
- The largest YoY upside for Debt to Equity was 19358.71% in 2023 against a maximum downside of 5696.78% in 2023.
- Year by year, Debt to Equity stood at -$0.01 in 2022, then sank by 5500.45% to -$0.73 in 2023, then surged by 74.44% to -$0.19 in 2024, then slumped by 174.45% to -$0.51 in 2025, then surged by 37.52% to -$0.32 in 2026.
- According to Business Quant data, Debt to Equity over the past three periods registered -$0.32, -$0.51, and -$0.26 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 1.39 |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 0.68 |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | -9.70 |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | 1.07 |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 6.24 |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 0.94 |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 0.72 |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Scilex Holding | 54.30 Mn | -95.62 Mn | 4.15 Mn | -0.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.32 |
| Dec 31, 2025 | -0.51 |
| Sep 30, 2025 | -0.26 |
| Jun 30, 2025 | -0.16 |
| Mar 31, 2025 | -0.19 |
| Dec 31, 2024 | -0.19 |
| Sep 30, 2024 | -0.47 |
| Jun 30, 2024 | -0.49 |
| Mar 31, 2024 | -0.58 |
| Dec 31, 2023 | -0.73 |
| Sep 30, 2023 | -0.75 |
| Jun 30, 2023 | 1.53 |
| Sep 30, 2022 | -0.01 |
| Jun 30, 2022 | -0.01 |
| Dec 31, 2021 | -0.49 |